Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00798356 · ClinicalTrials.gov registry record · NA

Yoga on Arrhythmia Burden and Quality of Life in Paroxysmal Atrial Fibrillation

A NA study of Atrial Fibrillation, sponsored by Dhanunjaya Lakkireddy, MD, FACC.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT00798356 is a NA study of Atrial Fibrillation that has completed, run by Dhanunjaya Lakkireddy, MD, FACC. The registered enrollment target is 84 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00798356, a NA study of Atrial Fibrillation, has completed, sponsored by Dhanunjaya Lakkireddy, MD, FACC.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

Studies in the past have shown that yoga could relieve stress which is the most common trigger for recurrent episodes of atrial fibrillation. Breathing exercises in yoga are found to influence the autonomic nervous system (particularly parasympathetic) and thus reduce palpitations. This study hypothesizes that patients with atrial fibrillation might benefit by practicing yoga. Yoga may also help to better control heart rate and rhythm when used in combination with usual medical management.

Conditions Studied

Interventions

  • OTHER Yoga training

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2008-11
Est. Completion 2012-01
Phase NA

Sponsor

Dhanunjaya Lakkireddy, MD, FACC

7 total trials

What the Registry Record Tells You About NCT00798356

The ClinicalTrials.gov registry entry for NCT00798356 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The listed sponsor is Dhanunjaya Lakkireddy, MD, FACC, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Yoga training is the first listed.

NCT00798356 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT00798356 about?

NCT00798356 is a clinical study titled "Yoga on Arrhythmia Burden and Quality of Life in Paroxysmal Atrial Fibrillation". Studies in the past have shown that yoga could relieve stress which is the most common trigger for recurrent episodes of atrial fibrillation. Breathing exercises in yoga are found to influence the autonomic nervous system (particularly parasympathetic) and thus reduce palpitations. This study hypoth...

What is the current status of trial NCT00798356?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2008-11. Estimated completion is 2012-01.

What conditions does trial NCT00798356 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT00798356?

The interventions under investigation include: Yoga training (OTHER).

Who is sponsoring clinical trial NCT00798356?

This trial is sponsored by Dhanunjaya Lakkireddy, MD, FACC, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00798356 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.